Clinical and Functional Significance of Intracellular and Extracellular microRNA-25-3p in Osteosarcoma

Although there is considerable evidence indicating that the dysregulation of microRNAs (miRNAs) in malignant tumors plays a role in tumor development, the overall function of miRNAs and their clinicopathological significance are not well understood. In this retrospective analysis of 45 biopsy specim...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta medica Okayama 2018-04, Vol.72 (2), p.165-174
Hauptverfasser: Yoshida, Aki, Fujiwara, Tomohiro, Uotani, Koji, Morita, Takuya, Kiyono, Masahiro, Yokoo, Suguru, Hasei, Joe, Nakata, Eiji, Kunisada, Toshiyuki, Ozaki, Toshifumi
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 174
container_issue 2
container_start_page 165
container_title Acta medica Okayama
container_volume 72
creator Yoshida, Aki
Fujiwara, Tomohiro
Uotani, Koji
Morita, Takuya
Kiyono, Masahiro
Yokoo, Suguru
Hasei, Joe
Nakata, Eiji
Kunisada, Toshiyuki
Ozaki, Toshifumi
description Although there is considerable evidence indicating that the dysregulation of microRNAs (miRNAs) in malignant tumors plays a role in tumor development, the overall function of miRNAs and their clinicopathological significance are not well understood. In this retrospective analysis of 45 biopsy specimens from osteosarcoma (OS) patients, we investigated the functional and clinical significance of miR-25-3p in OS, which we previously identified as a highly expressed miRNA in OS patients' serum. We observed that miR-25-3p dysregulation in human OS tissues was negatively correlated with the clinical prognosis, whereas the expression level of its target gene, Dickkopf WNT Signaling Pathway Inhibitor 3 (DKK3), was positively correlated with the clinical prognosis. Endogenous miR-25-3p upregulation promoted tumor growth, invasion, and drug resistance, which was consistent with DKK3 silencing in OS cells. In addition, secretory miR-25-3p was embedded in tumor-derived exosomes, where it promoted capillary formation and the invasion of vascular endothelial cells. Overall, our results show that miR-25-3p has intracellular and extracellular oncogenic functions as well as clinicopathological relevance in OS, indicating its potential as a novel diagnostic and therapeutic tool for the clinical management of this disease.
doi_str_mv 10.18926/amo/55857
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2028960903</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2028960903</sourcerecordid><originalsourceid>FETCH-LOGICAL-c427t-91fdf907abf176d60cbc380b7d0c4743b355c7eb219f1eb97b54cfe7b24358a53</originalsourceid><addsrcrecordid>eNpNkF1LwzAUhnOhuDm98QdIL72pS_PZXI6yzcFw4Ad4V5I0kUib1KQF_fdWneDV4T3vw-HwAHBVwNuiFIgtZReWlJaUn4A5xCXLMYQvM3Ce0huEiAgGz8AMCcYJZ3QObNU677RsM-mbbDN6Pbjgp_joXr2zU-O1yYLNdn6IUpu2HVsZf-D1x_9N53QMD_erHNEc95nz2SENJiQZdejkBTi1sk3m8jgX4Hmzfqru8v1hu6tW-1wTxIdcFLaxAnKpbMFZw6BWGpdQ8QZqwglWmFLNjUKFsIVRgitKtDVcIYJpKSlegJvfu30M76NJQ9259P2j9CaMqUYQlZMCAfGEXh_RUXWmqfvoOhk_6z83-AsUumQr</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2028960903</pqid></control><display><type>article</type><title>Clinical and Functional Significance of Intracellular and Extracellular microRNA-25-3p in Osteosarcoma</title><source>Freely Accessible Japanese Titles</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Yoshida, Aki ; Fujiwara, Tomohiro ; Uotani, Koji ; Morita, Takuya ; Kiyono, Masahiro ; Yokoo, Suguru ; Hasei, Joe ; Nakata, Eiji ; Kunisada, Toshiyuki ; Ozaki, Toshifumi</creator><creatorcontrib>Yoshida, Aki ; Fujiwara, Tomohiro ; Uotani, Koji ; Morita, Takuya ; Kiyono, Masahiro ; Yokoo, Suguru ; Hasei, Joe ; Nakata, Eiji ; Kunisada, Toshiyuki ; Ozaki, Toshifumi</creatorcontrib><description>Although there is considerable evidence indicating that the dysregulation of microRNAs (miRNAs) in malignant tumors plays a role in tumor development, the overall function of miRNAs and their clinicopathological significance are not well understood. In this retrospective analysis of 45 biopsy specimens from osteosarcoma (OS) patients, we investigated the functional and clinical significance of miR-25-3p in OS, which we previously identified as a highly expressed miRNA in OS patients' serum. We observed that miR-25-3p dysregulation in human OS tissues was negatively correlated with the clinical prognosis, whereas the expression level of its target gene, Dickkopf WNT Signaling Pathway Inhibitor 3 (DKK3), was positively correlated with the clinical prognosis. Endogenous miR-25-3p upregulation promoted tumor growth, invasion, and drug resistance, which was consistent with DKK3 silencing in OS cells. In addition, secretory miR-25-3p was embedded in tumor-derived exosomes, where it promoted capillary formation and the invasion of vascular endothelial cells. Overall, our results show that miR-25-3p has intracellular and extracellular oncogenic functions as well as clinicopathological relevance in OS, indicating its potential as a novel diagnostic and therapeutic tool for the clinical management of this disease.</description><identifier>ISSN: 0386-300X</identifier><identifier>DOI: 10.18926/amo/55857</identifier><identifier>PMID: 29674765</identifier><language>eng</language><publisher>Japan</publisher><ispartof>Acta medica Okayama, 2018-04, Vol.72 (2), p.165-174</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c427t-91fdf907abf176d60cbc380b7d0c4743b355c7eb219f1eb97b54cfe7b24358a53</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29674765$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yoshida, Aki</creatorcontrib><creatorcontrib>Fujiwara, Tomohiro</creatorcontrib><creatorcontrib>Uotani, Koji</creatorcontrib><creatorcontrib>Morita, Takuya</creatorcontrib><creatorcontrib>Kiyono, Masahiro</creatorcontrib><creatorcontrib>Yokoo, Suguru</creatorcontrib><creatorcontrib>Hasei, Joe</creatorcontrib><creatorcontrib>Nakata, Eiji</creatorcontrib><creatorcontrib>Kunisada, Toshiyuki</creatorcontrib><creatorcontrib>Ozaki, Toshifumi</creatorcontrib><title>Clinical and Functional Significance of Intracellular and Extracellular microRNA-25-3p in Osteosarcoma</title><title>Acta medica Okayama</title><addtitle>Acta Med Okayama</addtitle><description>Although there is considerable evidence indicating that the dysregulation of microRNAs (miRNAs) in malignant tumors plays a role in tumor development, the overall function of miRNAs and their clinicopathological significance are not well understood. In this retrospective analysis of 45 biopsy specimens from osteosarcoma (OS) patients, we investigated the functional and clinical significance of miR-25-3p in OS, which we previously identified as a highly expressed miRNA in OS patients' serum. We observed that miR-25-3p dysregulation in human OS tissues was negatively correlated with the clinical prognosis, whereas the expression level of its target gene, Dickkopf WNT Signaling Pathway Inhibitor 3 (DKK3), was positively correlated with the clinical prognosis. Endogenous miR-25-3p upregulation promoted tumor growth, invasion, and drug resistance, which was consistent with DKK3 silencing in OS cells. In addition, secretory miR-25-3p was embedded in tumor-derived exosomes, where it promoted capillary formation and the invasion of vascular endothelial cells. Overall, our results show that miR-25-3p has intracellular and extracellular oncogenic functions as well as clinicopathological relevance in OS, indicating its potential as a novel diagnostic and therapeutic tool for the clinical management of this disease.</description><issn>0386-300X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNpNkF1LwzAUhnOhuDm98QdIL72pS_PZXI6yzcFw4Ad4V5I0kUib1KQF_fdWneDV4T3vw-HwAHBVwNuiFIgtZReWlJaUn4A5xCXLMYQvM3Ce0huEiAgGz8AMCcYJZ3QObNU677RsM-mbbDN6Pbjgp_joXr2zU-O1yYLNdn6IUpu2HVsZf-D1x_9N53QMD_erHNEc95nz2SENJiQZdejkBTi1sk3m8jgX4Hmzfqru8v1hu6tW-1wTxIdcFLaxAnKpbMFZw6BWGpdQ8QZqwglWmFLNjUKFsIVRgitKtDVcIYJpKSlegJvfu30M76NJQ9259P2j9CaMqUYQlZMCAfGEXh_RUXWmqfvoOhk_6z83-AsUumQr</recordid><startdate>20180401</startdate><enddate>20180401</enddate><creator>Yoshida, Aki</creator><creator>Fujiwara, Tomohiro</creator><creator>Uotani, Koji</creator><creator>Morita, Takuya</creator><creator>Kiyono, Masahiro</creator><creator>Yokoo, Suguru</creator><creator>Hasei, Joe</creator><creator>Nakata, Eiji</creator><creator>Kunisada, Toshiyuki</creator><creator>Ozaki, Toshifumi</creator><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20180401</creationdate><title>Clinical and Functional Significance of Intracellular and Extracellular microRNA-25-3p in Osteosarcoma</title><author>Yoshida, Aki ; Fujiwara, Tomohiro ; Uotani, Koji ; Morita, Takuya ; Kiyono, Masahiro ; Yokoo, Suguru ; Hasei, Joe ; Nakata, Eiji ; Kunisada, Toshiyuki ; Ozaki, Toshifumi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c427t-91fdf907abf176d60cbc380b7d0c4743b355c7eb219f1eb97b54cfe7b24358a53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yoshida, Aki</creatorcontrib><creatorcontrib>Fujiwara, Tomohiro</creatorcontrib><creatorcontrib>Uotani, Koji</creatorcontrib><creatorcontrib>Morita, Takuya</creatorcontrib><creatorcontrib>Kiyono, Masahiro</creatorcontrib><creatorcontrib>Yokoo, Suguru</creatorcontrib><creatorcontrib>Hasei, Joe</creatorcontrib><creatorcontrib>Nakata, Eiji</creatorcontrib><creatorcontrib>Kunisada, Toshiyuki</creatorcontrib><creatorcontrib>Ozaki, Toshifumi</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Acta medica Okayama</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yoshida, Aki</au><au>Fujiwara, Tomohiro</au><au>Uotani, Koji</au><au>Morita, Takuya</au><au>Kiyono, Masahiro</au><au>Yokoo, Suguru</au><au>Hasei, Joe</au><au>Nakata, Eiji</au><au>Kunisada, Toshiyuki</au><au>Ozaki, Toshifumi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical and Functional Significance of Intracellular and Extracellular microRNA-25-3p in Osteosarcoma</atitle><jtitle>Acta medica Okayama</jtitle><addtitle>Acta Med Okayama</addtitle><date>2018-04-01</date><risdate>2018</risdate><volume>72</volume><issue>2</issue><spage>165</spage><epage>174</epage><pages>165-174</pages><issn>0386-300X</issn><abstract>Although there is considerable evidence indicating that the dysregulation of microRNAs (miRNAs) in malignant tumors plays a role in tumor development, the overall function of miRNAs and their clinicopathological significance are not well understood. In this retrospective analysis of 45 biopsy specimens from osteosarcoma (OS) patients, we investigated the functional and clinical significance of miR-25-3p in OS, which we previously identified as a highly expressed miRNA in OS patients' serum. We observed that miR-25-3p dysregulation in human OS tissues was negatively correlated with the clinical prognosis, whereas the expression level of its target gene, Dickkopf WNT Signaling Pathway Inhibitor 3 (DKK3), was positively correlated with the clinical prognosis. Endogenous miR-25-3p upregulation promoted tumor growth, invasion, and drug resistance, which was consistent with DKK3 silencing in OS cells. In addition, secretory miR-25-3p was embedded in tumor-derived exosomes, where it promoted capillary formation and the invasion of vascular endothelial cells. Overall, our results show that miR-25-3p has intracellular and extracellular oncogenic functions as well as clinicopathological relevance in OS, indicating its potential as a novel diagnostic and therapeutic tool for the clinical management of this disease.</abstract><cop>Japan</cop><pmid>29674765</pmid><doi>10.18926/amo/55857</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0386-300X
ispartof Acta medica Okayama, 2018-04, Vol.72 (2), p.165-174
issn 0386-300X
language eng
recordid cdi_proquest_miscellaneous_2028960903
source Freely Accessible Japanese Titles; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
title Clinical and Functional Significance of Intracellular and Extracellular microRNA-25-3p in Osteosarcoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T09%3A43%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20and%20Functional%20Significance%20of%20Intracellular%20and%20Extracellular%20microRNA-25-3p%20in%20Osteosarcoma&rft.jtitle=Acta%20medica%20Okayama&rft.au=Yoshida,%20Aki&rft.date=2018-04-01&rft.volume=72&rft.issue=2&rft.spage=165&rft.epage=174&rft.pages=165-174&rft.issn=0386-300X&rft_id=info:doi/10.18926/amo/55857&rft_dat=%3Cproquest_pubme%3E2028960903%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2028960903&rft_id=info:pmid/29674765&rfr_iscdi=true